PubMed中文版
| PubMed ID | 41405876 |
|---|---|
| 发表日期 | 2025-12-17 |
| 作者 | |
| 文献标题 | Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: Research Summary. |
| 原始出处 | JAMA |
| 影响因子 | 55 期刊引文指标 11.47 |
| PubMed ID | 41359335 |
|---|---|
| 发表日期 | 2025-12-01 |
| 作者 | Cantoni V, Casula EP, Tarantino B, Cupidi C, Huber N, Altomare D, Premi E, Zummo E, Esposito R, Leonardi C, Herukka SK, Solje E, Ferrari A, Cotelli MS, Gasparotti R, Martorana A, Fracassi C, Santarnecchi E, Koch G, Haapasalo A, Grassi M, Benussi A, Borroni B. |
| 文献标题 | Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial. |
| 原始出处 | JAMA Netw Open |
| 影响因子 | 9.7 期刊引文指标 2.95 |
| PubMed ID | 41312794 |
|---|---|
| 发表日期 | 2025-11-28 |
| 作者 | Healy M, Thomas S, Brodtmann A. |
| 文献标题 | Magnetic resonance imaging eligibility for anti-amyloid monoclonal antibody treatment for Alzheimer disease: a single-centre retrospective review for service planning. |
| 原始出处 | Intern Med J |
| 影响因子 | 1.5 期刊引文指标 0.47 |
| PubMed ID | 41290365 |
|---|---|
| 发表日期 | 2025-11-25 |
| 作者 | Chiotis K, Wang Y, La Joie R, Rabinovici GD. |
| 文献标题 | The Role of Amyloid-β and Tau PET in the New Era of Alzheimer Disease Therapies. |
| 原始出处 | J Nucl Med |
| 影响因子 | 9.1 期刊引文指标 2.88 |
| PubMed ID | 41252538 |
|---|---|
| 发表日期 | 2025-11-18 |
| 作者 | Depp C, Holden J, Granholm E. |
| 文献标题 | Digital Measurement of Subjective Experiences in Alzheimer Disease and Related Dementias (AD/ADRD). |
| 原始出处 | JMIR Aging |
| 影响因子 | 4.8 期刊引文指标 1.11 |
| PubMed ID | 40855593 |
|---|---|
| 发表日期 | 2025-08-28 |
| 作者 | Foreman RM, Rodriguez M. |
| 文献标题 | Understanding the correlative relationship between obesity and Alzheimer disease. |
| 原始出处 | Nurse Pract |
| 影响因子 | 0.9 期刊引文指标 0.35 |
| PubMed ID | 40639970 |
|---|---|
| 发表日期 | 2025-08-01 |
| 作者 | Franceschi AM, Keir G, Benzinger TLS, Cogswell PM, Ali FZ, Petrella JR, Prescott JW, Whitlow CT, Zaharchuk G, Allen JW, American Society of Functional Neuroradiology (ASFNR). |
| 文献标题 | Clinical Role of Brain PET in Alzheimer Disease in the Era of Disease-Modifying Therapies. |
| 原始出处 | AJNR Am J Neuroradiol |
| 影响因子 | 3.7 期刊引文指标 1.02 |
| PubMed ID | 40736488 |
|---|---|
| 发表日期 | 2025-07-01 |
| 作者 | Johnston EM, Lounsbery JL. |
| 文献标题 | Benzgalantamine (Zunveyl) for the Treatment of Mild to Moderate Alzheimer Disease. |
| 原始出处 | Am Fam Physician |
| 影响因子 | 3.5 期刊引文指标 1.63 |
| PubMed ID | 40552995 |
|---|---|
| 发表日期 | 2025-06-01 |
| 作者 | Shepherd TM. |
| 文献标题 | Imaging the Treatment of Alzheimer Disease: 2030 Could Look Very Different. |
| 原始出处 | Radiology |
| 影响因子 | 15.2 期刊引文指标 4.16 |
| PubMed ID | 40554071 |
|---|---|
| 发表日期 | 2025-05-19 |
| 作者 | Wang F, Zhou Q, Chen Z, Xie L, Zheng N, Chen Z, Sun Q, Du J, Lin J, Li B, Li L. |
| 文献标题 | Cyclovirobuxine inhibits ferroptosis to mitigate Alzheimer disease in glutamate-induced SH-SY5Y cell: the role of the liquid-liquid phase separation of FTH1. |
| 原始出处 | Mol Pharmacol |
| 影响因子 | 3 期刊引文指标 0.76 |
| PubMed ID | 40042516 |
|---|---|
| 发表日期 | 2025-03-01 |
| 作者 | Dohl J, Treadwell Z, Norris C, Head E. |
| 文献标题 | Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome. |
| 原始出处 | Alzheimers Dement |
| 影响因子 | 11.1 期刊引文指标 3.34 |
| PubMed ID | 39868701 |
|---|---|
| 发表日期 | 2025-01-27 |
| 作者 | Keränen E, Rysä J, Tiihonen M, Hartikainen S, Tolppanen AM. |
| 文献标题 | Helicobacter pylori Eradication Treatments and Risk of Alzheimer Disease: A Case-Control Study Nested in the Finnish Population. |
| 原始出处 | Epidemiology |
| 影响因子 | 4.4 期刊引文指标 1.37 |
| PubMed ID | 40340060 |
|---|---|
| 发表日期 | 2025-01-01 |
| 作者 | Fisher A, Levey AI. |
| 文献标题 | CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatment. |
| 原始出处 | Handb Clin Neurol |
| 影响因子 |
| PubMed ID | 39570769 |
|---|---|
| 发表日期 | 2024-11-20 |
| 作者 | Shuja MH, Imran H, Abid M, Ibrahim Ahmed F. |
| 文献标题 | Evaluating Donanemab: Advances and Challenges in Alzheimer Disease Treatment. |
| 原始出处 | Am J Ther |
| 影响因子 | 2.5 期刊引文指标 0.61 |
| PubMed ID | 39792495 |
|---|---|
| 发表日期 | 2024-11-01 |
| 作者 | Espay AJ, Espay AJ. |
| 文献标题 | From Europe to the World: EMA's Leadership in Alzheimer Disease Treatment. |
| 原始出处 | Am J Ther |
| 影响因子 | 2.5 期刊引文指标 0.61 |
| PubMed ID | 39283851 |
|---|---|
| 发表日期 | 2024-09-01 |
| 作者 | Jaqua EE, Tran MN, Hanna M. |
| 文献标题 | Alzheimer Disease: Treatment of Cognitive and Functional Symptoms. |
| 原始出处 | Am Fam Physician |
| 影响因子 | 3.5 期刊引文指标 1.63 |
| PubMed ID | 38175625 |
|---|---|
| 发表日期 | 2024-02-01 |
| 作者 | Sutton SS, Magagnoli J, Cummings TH, Hardin JW, Ambati J. |
| 文献标题 | Alzheimer Disease Treatment With Acetylcholinesterase Inhibitors and Incident Age-Related Macular Degeneration. |
| 原始出处 | JAMA Ophthalmol |
| 影响因子 | 9.2 期刊引文指标 3.81 |
| PubMed ID | 37655700 |
|---|---|
| 发表日期 | 2023-09-01 |
| 作者 | El Alaouy MA, Alaqarbeh M, Ouabane M, Zaki H, ElBouhi M, Badaoui H, Moukhliss Y, Sbai A, Maghat H, Lakhlifi T, Bouachrine M. |
| 文献标题 | Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox. |
| 原始出处 | J Biomol Struct Dyn |
| 影响因子 | 2.4 期刊引文指标 0.66 |
| PubMed ID | 37422087 |
|---|---|
| 发表日期 | 2023-07-07 |
| 作者 | Jeremic D, Jiménez-Díaz L, Navarro-López JD. |
| 文献标题 | Targeting epigenetics: A novel promise for Alzheimer's disease treatment. |
| 原始出处 | Ageing Res Rev |
| 影响因子 | 12.4 期刊引文指标 1.68 |
| PubMed ID | 33390886 |
|---|---|
| 发表日期 | 2020-12-18 |
| 作者 | Zhou Y, Chen Y, Xu C, Zhang H, Lin C. |
| 文献标题 | TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment. |
| 原始出处 | Front Neurosci |
| 影响因子 |